drugset / Trial / NCT02082756
Effects of Berberine Hydrochloride and Bifidobacterium in Prediabetes Prevention and Treatment
RandomizedParallel-groupOpen-labelPrevention
Summary
The aim of this study is to assess the beneficial effects of Bifidobacterium and Berberine Hydrochloride on lowering glucose and delaying progress to diabetes in patients with prediabetes and to detect the potential mechanism.
Timeline
- Start
- 2015-11
- Primary completion
- 2018-04
- Completion
- 2018-04
Outcome
Outcome not reported
Stopped: “The sponsor have not enough money to support this trial”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Berberine | Traditional medicine (herbal / TCM) | 0.5 g | — |
| Subject | Bifidobacterium viable pharmaceutics | Other / unclassified | — | — |